Publications by authors named "Christopher H Domen"

Claim this Profile
S
Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial.
Ying Liu, Jacquelyn Bainbridge, Stefan Sillau, Sarah Rajkovic, Michelle Adkins, Christopher H Domen

Mov Disord· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Cognitive Safety of Cannabis Products in Parkinson's Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds.
Christopher H Domen, Stefan Sillau, Ying Liu, Maureen A Leehey

Mov Disord· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms.
Christopher H Domen, Stefan Sillau, Ying Liu, Michelle Adkins, Sarah Rajkovic

Mov Disord· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Risk, Higher Reward? Self-Reported Effects of Real-World Cannabis Use in Parkinson's Disease.
Samantha K Holden, Christopher H Domen, Stefan Sillau, Ying Liu, Maureen A Leehey

Mov Disord Clin Pract· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The APPCN multisite didactic initiative: Development, benefits, and challenges.
Christopher H Domen, Robert L Collins, Jeremy J Davis

Clin Neuropsychol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing two models of performance validity assessment in patients with Parkinson's disease who are candidates for deep brain stimulation surgery.
Thomas R Wodushek, Christopher H Domen

Appl Neuropsychol Adult· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Established Embedded Performance Validity Test Cut-Offs Generalizable to Patients With Multiple Sclerosis?
Christopher H Domen, Michael R Greher, Patrick W Hosokawa, Sierra L Barnes, Brian D Hoyt

Arch Clin Neuropsychol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of cannabis use on intracarotid amobarbital testing.
Christopher H Domen, Archana Shrestha, Kevin Chapman, Cornelia Drees

Epilepsy Behav Rep· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
Laura Weinkle, Christopher H Domen, Ian Shelton, Stefan Sillau, Kavita Nair

Mult Scler Relat Disord· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis